• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: A Role for Extended VTE Prophylaxis After Neoadjuvant Therapy and Distal Pancreatectomy for Pancreatic Adenocarcinoma.

作者信息

Robbins Keenan J, Hawkins William G

机构信息

Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.

MUSC, Hollings Cancer Center, Charelston, SC, USA.

出版信息

Ann Surg Oncol. 2024 May;31(5):2965-2966. doi: 10.1245/s10434-023-14849-7. Epub 2024 Jan 12.

DOI:10.1245/s10434-023-14849-7
PMID:38214818
Abstract
摘要

相似文献

1
ASO Author Reflections: A Role for Extended VTE Prophylaxis After Neoadjuvant Therapy and Distal Pancreatectomy for Pancreatic Adenocarcinoma.ASO作者反思：新辅助治疗和远端胰腺切除术后延长静脉血栓栓塞预防在胰腺腺癌治疗中的作用
Ann Surg Oncol. 2024 May;31(5):2965-2966. doi: 10.1245/s10434-023-14849-7. Epub 2024 Jan 12.
2
Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.接受新辅助化疗后手术切除的胰腺导管腺癌患者的静脉血栓栓塞风险。
Ann Surg Oncol. 2019 May;26(5):1503-1511. doi: 10.1245/s10434-018-07148-z. Epub 2019 Jan 16.
3
Is new risk-assessment score of venous thromboembolism for hospitalized surgical patients with borderline resectable pancreatic adenocarcinoma needed?对于边缘可切除的胰腺腺癌住院手术患者，是否需要新的静脉血栓栓塞风险评估评分？
Asian J Surg. 2023 Apr;46(4):1824-1825. doi: 10.1016/j.asjsur.2022.10.052. Epub 2022 Nov 9.
4
Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?可切除及边界可切除胰腺癌新辅助治疗期间的静脉血栓栓塞预防——是否有必要？
J Surg Oncol. 2016 Oct;114(5):581-586. doi: 10.1002/jso.24361. Epub 2016 Oct 19.
5
ASO Author Reflections: Dissecting the Risk and Impact of Venous Thromboembolism During Neoadjuvant Treatment and the Subsequent Perioperative Period for Patients With Pancreatic Adenocarcinoma.
Ann Surg Oncol. 2019 Dec;26(Suppl 3):590-591. doi: 10.1245/s10434-019-07396-7. Epub 2019 Apr 23.
6
Assessing the use of Extended Venous Thromboembolism Prophylaxis on the Rates of Venous Thromboembolism and Postpancreatectomy Hemorrhage Following Pancreatectomy for Malignancy.评估Extended Venous Thromboembolism Prophylaxis（Extended Venous Thromboembolism Prophylaxis）在恶性肿瘤胰切除术后静脉血栓栓塞（Venous Thromboembolism）和胰切除术后出血（Postpancreatectomy Hemorrhage）发生率中的应用。
Ann Surg. 2023 Jul 1;278(1):e80-e86. doi: 10.1097/SLA.0000000000005483. Epub 2022 Jul 7.
7
ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.ASO作者反思：全身免疫炎症指数（SII）作为胰腺腺癌患者新辅助治疗反应的生物标志物
Ann Surg Oncol. 2020 Mar;27(3):907-908. doi: 10.1245/s10434-019-08136-7. Epub 2019 Dec 10.
8
ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes.ASO作者反思：接受胰十二指肠切除术的可切除和边界可切除胰腺导管腺癌患者的新辅助放化疗改变身体成分，影响长期预后。
Ann Surg Oncol. 2023 Apr;30(4):2469-2470. doi: 10.1245/s10434-022-13024-8. Epub 2022 Dec 25.
9
Distal pancreatectomy with en bloc celiac axis resection after neoadjuvant therapy for locally advanced pancreatic adenocarcinoma.新辅助治疗后对局部晚期胰腺腺癌行胰体尾切除术并整块切除腹腔干
Pancreas. 2010 Oct;39(7):1111-3. doi: 10.1097/MPA.0b013e3181df2754.
10
ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.ASO作者反思：胰腺癌新辅助化疗后辅助化疗并非能提高所有患者的生存率。
Ann Surg Oncol. 2021 Jun;28(6):3123. doi: 10.1245/s10434-021-09615-6. Epub 2021 Feb 22.

本文引用的文献

1
Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis.新辅助化疗与胰腺腺癌胰体尾切除术后术后深静脉血栓形成风险增加相关：一项 NSQIP 分析。
Ann Surg Oncol. 2024 May;31(5):2873-2881. doi: 10.1245/s10434-023-14763-y. Epub 2023 Dec 27.
2
Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.新辅助治疗与早期左侧胰腺腺癌的 upfront 手术治疗：来自全国远端胰腺切除术队列的倾向性匹配分析。
J Surg Oncol. 2021 Jan;123(1):245-251. doi: 10.1002/jso.26267. Epub 2020 Oct 25.
3
Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
非骨科手术患者静脉血栓栓塞症的预防：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e227S-e277S. doi: 10.1378/chest.11-2297.
4
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.癌症手术后使用依诺肝素预防静脉血栓栓塞的持续时间。
N Engl J Med. 2002 Mar 28;346(13):975-80. doi: 10.1056/NEJMoa012385.